Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses

References

• World Health OrganisationInternational Statistical Classification of Diseases and Related Health ProblemsTenth Revision. Anonymous International Statistical Classification of Diseases and Health Related ProblemsGeneva1992
   Google Scholar
• McgrotherCWBhaumikSThorpCFHauckABranfordDWatsonJMEpilepsy in adults with intellectual disabilities: prevalence, associations and service implicationsSeizure200615637638616782360
   PubMed Web of Science ®Google Scholar
• CawelloWClinical pharmacokinetic and pharmacodynamic profile of lacosamideClin Pharmacokinet201554990191425957198
   PubMed Web of Science ®Google Scholar
• KellinghausCLacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safetyTher Clin Risk Manag2009575776619816574
   PubMedGoogle Scholar
• LennoxNTaylorMRey-CondeTBainCPurdieDMBoyleFBeating the barriers: recruitment of people with intellectual disability to participate in researchJ Intellect Disabil Res200549Pt 429630515816817
   PubMed Web of Science ®Google Scholar
• AAIDD (American Association on Intellectual Developmental Disabilities)Intellectual disability: Definition, classification, and systems of supportsWashington, DCAAIDD2010
   Google Scholar
• APA (American Psychiatric Association)2013. Diagnostic and statistical manual of mental disorders, fifth edition. Diagnostic and Statistical Manual of Mental Disorders Diagnostic and statistical manual of mental disorders5th edWashington, DC WashingtonAPADC2013
   Google Scholar
• BrodieMJSodium Channel Blockers in the Treatment of EpilepsyCNS Drugs201731752753428523600
   PubMed Web of Science ®Google Scholar
• BrennerJMajoieHJMvan BeekSCarpayJAThe retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutionsSeizure20175212313029031193
   PubMed Web of Science ®Google Scholar
• BöttcherSLutzMTMayerTLacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patientsEpilepsia201758101749175428804872
   PubMed Web of Science ®Google Scholar
• McgintyRNCostelloDJLong-term lacosamide retention-Real-world experience at a tertiary epilepsy center in IrelandEpilepsy Behav20176814114528183037
   PubMed Web of Science ®Google Scholar
• ZaccaraGGiovannelliFMarateaDFaddaVVerrottiANeurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepineSeizure201322752853623623245
   PubMed Web of Science ®Google Scholar
• McginnisEKesslerSKLacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohortEpilepsia20165791416142527430392
   PubMed Web of Science ®Google Scholar
• KamelJTDegruyterMAD’SouzaWJCookMJClinical experience with using lacosamide for the treatment of epilepsy in a tertiary centreActa Neurol Scand2013127314915322845761
   PubMed Web of Science ®Google Scholar
• NovyJPatsalosPNSanderJWSisodiyaSMLacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?Epilepsy Behav2011201202321056937
   PubMed Web of Science ®Google Scholar
• SakeJKHebertDIsojärviJA pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugsCNS Drugs201024121055106821090839
   PubMed Web of Science ®Google Scholar
• VillanuevaVGarcésMLópez-GomárizEEarly add-on lacosamide in a real-life setting: results of the REALLY studyClin Drug Investig2015352121131
   Web of Science ®Google Scholar
• NealAD’SouzaWHepworthGLawnNCookMNikpourAEfficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDsEpilepsy Behav201880253229396359
   PubMed Web of Science ®Google Scholar
• Ben-MenachemESanderJWPriviteraMGilliamFMeasuring outcomes of treatment with antiepileptic drugs in clinical trialsEpilepsy Behav2010181–2243020462803
   PubMed Web of Science ®Google Scholar
• ILAE Commission on Antiepileptic DrugsConsiderations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsyEpilepsia19983977998039670910
   PubMed Web of Science ®Google Scholar
• LandoltHOn various correlations between the electro-encephalogram and normal and pathological psychic processesSchweiz Med Wochenschr19639310711013928479
   PubMedGoogle Scholar
• StephenLJWishartABrodieMJPsychiatric side effects and anti-epileptic drugs: Observations from prospective auditsEpilepsy Behav201771Pt A737828551500
   PubMed Web of Science ®Google Scholar
• EspieCAWatkinsJCurticeLPsychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variablesJ Neurol Neurosurg Psychiatry200374111485149214617702
   PubMed Web of Science ®Google Scholar
• RingHZiaALindemanSHimlokKInteractions between seizure frequency, psychopathology, and severity of intellectual disability in a population with epilepsy and a learning disabilityEpilepsy Behav2007111929717521964
   PubMed Web of Science ®Google Scholar
• KrishnamoorthyESTrimbleMRSanderJWKannerAMForced normalization at the interface between epilepsy and psychiatryEpilepsy Behav20023430330812609326
   PubMed Web of Science ®Google Scholar
• WolfPAcute behavioral symptomatology at disappearance of epileptiform EEG abnormality: paradoxical or forced normalisationSmithDTriemanDTrimbleMR55New York, NYNeurobehavioral problems in EpilepsyRaven Press1991127142
   Google Scholar
• KrishnamoorthyESTrimbleMRBlumerDThe classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of EpilepsyEpilepsy Behav200710334935317344100
   PubMed Web of Science ®Google Scholar
• PollockDCModels for understanding the antagonism between seizures and psychosisProg Neuropsychopharmacol Biol Psychiatry19871144835043321151
   PubMed Web of Science ®Google Scholar
• PinkhasovALamTHayesDFriedmanMSinghDCohenHLacosamide Induced Psychosis: Case Report, Review of Differential Diagnosis and Relevant PharmacokineticsClin Neuropharmacol201538519820026366962
   PubMed Web of Science ®Google Scholar
• Abou KhaledKKhouryJMacaronGRichaSForced normalization and psychosis following use of lacosamideSeizure201641969927522575
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration FDA Vimpat (lacosamide) Prescribing Information2014
   Google Scholar